Literature DB >> 33680990

Toxoplasma GRA Peptide-Specific Serologic Fingerprints Discriminate Among Major Strains Causing Toxoplasmosis.

David Arranz-Solís1, Cristina G Carvalheiro2,3, Elizabeth R Zhang2, Michael E Grigg2, Jeroen P J Saeij1.   

Abstract

The severity of toxoplasmosis depends on a combination of host and parasite factors. Among them, the Toxoplasma strain causing the infection is an important determinant of the disease outcome. Type 2 strains dominate in Europe, whereas in North America type 2, followed by type 3 and 12 strains are commonly isolated from wildlife and patients. To identify the strain type a person is infected with, serological typing provides a promising alternative to the often risky and not always possible biopsy-based DNA methods of genotyping. However, despite recent advances in serotyping, improvements in the sensitivity and specificity are still needed, and it does not yet discriminate among the major Toxoplasma lineages infecting people. Moreover, since infections caused by non-1/2/3 strains have been associated with more severe disease, the ability to identify these is critical. In the present study we investigated the diagnostic potential of an ELISA-based assay using 28 immunogenic Toxoplasma peptides derived from a recent large-scale peptide array screen. Our results show that a discrete number of peptides, derived from Toxoplasma dense granule proteins (GRA3, GRA5, GRA6, and GRA7) was sufficient to discriminate among archetypal strains that infect mice and humans. The assay specifically relies on ratios that compare individual serum reactivities against GRA-specific polymorphic peptide variants in order to determine a "reactivity fingerprint" for each of the major strains. Importantly, nonarchetypal strains that possess a unique combination of alleles, different from types 1/2/3, showed either a non-reactive, or different combinatorial, mixed serum reactivity signature that was diagnostic in its own right, and that can be used to identify these strains. Of note, we identified a distinct "HG11/12" reactivity pattern using the GRA6 peptides that is able to distinguish HG11/12 from archetypal North American/European strain infections.
Copyright © 2021 Arranz-Solís, Carvalheiro, Zhang, Grigg and Saeij.

Entities:  

Keywords:  ELISA; Toxoplasma; dense granule; peptide; rhoptry; serotyping

Year:  2021        PMID: 33680990      PMCID: PMC7935526          DOI: 10.3389/fcimb.2021.621738

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  48 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type.

Authors:  J P Dubey; G V Velmurugan; C Rajendran; M J Yabsley; N J Thomas; K B Beckmen; D Sinnett; D Ruid; J Hart; P A Fair; W E McFee; V Shearn-Bochsler; O C H Kwok; L R Ferreira; S Choudhary; E B Faria; H Zhou; T A Felix; C Su
Journal:  Int J Parasitol       Date:  2011-07-19       Impact factor: 3.981

3.  Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America.

Authors:  Asis Khan; J P Dubey; Chunlei Su; James W Ajioka; Benjamin M Rosenthal; L David Sibley
Journal:  Int J Parasitol       Date:  2011-02-12       Impact factor: 3.981

4.  Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries.

Authors:  M E Grigg; S Bonnefoy; A B Hehl; Y Suzuki; J C Boothroyd
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

Review 5.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping.

Authors:  Susana Sousa; Daniel Ajzenberg; Maggy Marle; Dominique Aubert; Isabelle Villena; José Correia da Costa; Marie-Laure Dardé
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

7.  Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.

Authors:  Jianchun Xiao; Stephen L Buka; Tyrone D Cannon; Yasuhiro Suzuki; Raphael P Viscidi; E Fuller Torrey; Robert H Yolken
Journal:  Microbes Infect       Date:  2009-07-26       Impact factor: 2.700

8.  Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana.

Authors:  Bernard Carme; Magalie Demar; Daniel Ajzenberg; Marie Laure Dardé
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

9.  Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes.

Authors:  Hernan Lorenzi; Asis Khan; Michael S Behnke; Sivaranjani Namasivayam; Lakshmipuram S Swapna; Michalis Hadjithomas; Svetlana Karamycheva; Deborah Pinney; Brian P Brunk; James W Ajioka; Daniel Ajzenberg; John C Boothroyd; Jon P Boyle; Marie L Dardé; Maria A Diaz-Miranda; Jitender P Dubey; Heather M Fritz; Solange M Gennari; Brian D Gregory; Kami Kim; Jeroen P J Saeij; Chunlei Su; Michael W White; Xing-Quan Zhu; Daniel K Howe; Benjamin M Rosenthal; Michael E Grigg; John Parkinson; Liang Liu; Jessica C Kissinger; David S Roos; L David Sibley
Journal:  Nat Commun       Date:  2016-01-07       Impact factor: 14.919

10.  CCp5A Protein from Toxoplasma gondii as a Serological Marker of Oocyst-driven Infections in Humans and Domestic Animals.

Authors:  Silas S Santana; Luiz C Gebrim; Fernando R Carvalho; Heber S Barros; Patrício C Barros; Ana C A M Pajuaba; Valeria Messina; Alessia Possenti; Simona Cherchi; Edna M V Reiche; Italmar T Navarro; João L Garcia; Edoardo Pozio; Tiago W P Mineo; Furio Spano; José R Mineo
Journal:  Front Microbiol       Date:  2015-11-24       Impact factor: 5.640

View more
  3 in total

1.  Diagnostic value of recombinant nanoluciferase fused Toxoplasma gondii antigens in Luciferase-linked Antibody Capture Assay (LACA) for Toxoplasma infection in pigs.

Authors:  Hieu Duc Duong; Yuji Taniguchi; Yasuhiro Takashima; Satoshi Sekiguchi; Khin Myo Aye; Parnian Ahmadi; Linh Khanh Bui; Takao Irie; Eiji Nagayasu; Ayako Yoshida
Journal:  J Vet Med Sci       Date:  2022-05-18       Impact factor: 1.105

Review 2.  Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.

Authors:  Mariangela Soberón Felín; Kanix Wang; Aliya Moreira; Andrew Grose; Karen Leahy; Ying Zhou; Fatima Alibana Clouser; Maryam Siddiqui; Nicole Leong; Perpetua Goodall; Morgan Michalowski; Mahmoud Ismail; Monica Christmas; Stephen Schrantz; Zuleima Caballero; Ximena Norero; Dora Estripeaut; David Ellis; Catalina Raggi; Catherine Castro; Davina Moossazadeh; Margarita Ramirez; Abhinav Pandey; Kevin Ashi; Samantha Dovgin; Ashtyn Dixon; Xuan Li; Ian Begeman; Sharon Heichman; Joseph Lykins; Delba Villalobos-Cerrud; Lorena Fabrega; José Luis Sanchez Montalvo; Connie Mendivil; Mario R Quijada; Silvia Fernández-Pirla; Valli de La Guardia; Digna Wong; Mayrene Ladrón de Guevara; Carlos Flores; Jovanna Borace; Anabel García; Natividad Caballero; Claudia Rengifo-Herrera; Maria Theresa Moreno de Saez; Michael Politis; Kristen Wroblewski; Theodore Karrison; Stephanie Ross; Mimansa Dogra; Vishan Dhamsania; Nicholas Graves; Marci Kirchberg; Kopal Mathur; Ashley Aue; Carlos M Restrepo; Alejandro Llanes; German Guzman; Arturo Rebellon; Kenneth Boyer; Peter Heydemann; A Gwendolyn Noble; Charles Swisher; Peter Rabiah; Shawn Withers; Teri Hull; Chunlei Su; Michael Blair; Paul Latkany; Ernest Mui; Daniel Vitor Vasconcelos-Santos; Alcibiades Villareal; Ambar Perez; Carlos Andrés Naranjo Galvis; Mónica Vargas Montes; Nestor Ivan Cardona Perez; Morgan Ramirez; Cy Chittenden; Edward Wang; Laura Lorena Garcia-López; Juliana Muñoz-Ortiz; Nicolás Rivera-Valdivia; María Cristina Bohorquez-Granados; Gabriela Castaño de-la-Torre; Guillermo Padrieu; Juan David Valencia Hernandez; Daniel Celis-Giraldo; Juan Alejandro Acosta Dávila; Elizabeth Torres; Manuela Mejia Oquendo; José Y Arteaga-Rivera; Dan L Nicolae; Andrey Rzhetsky; Nancy Roizen; Eileen Stillwaggon; Larry Sawers; Francois Peyron; Martine Wallon; Emanuelle Chapey; Pauline Levigne; Carmen Charter; Migdalia De Frias; Jose Montoya; Cindy Press; Raymund Ramirez; Despina Contopoulos-Ioannidis; Yvonne Maldonado; Oliver Liesenfeld; Carlos Gomez; Kelsey Wheeler; Ellen Holfels; David Frim; David McLone; Richard Penn; William Cohen; Samantha Zehar; James McAuley; Denis Limonne; Sandrine Houze; Sylvie Abraham; Raphael Piarroux; Vera Tesic; Kathleen Beavis; Ana Abeleda; Mari Sautter; Bouchra El Mansouri; Adlaoui El Bachir; Fatima Amarir; Kamal El Bissati; Alejandra de-la-Torre; Gabrielle Britton; Jorge Motta; Eduardo Ortega-Barria; Isabel Luz Romero; Paul Meier; Michael Grigg; Jorge Gómez-Marín; Jagannatha Rao Kosagisharaf; Xavier Sáez Llorens; Osvaldo Reyes; Rima McLeod
Journal:  Curr Pediatr Rep       Date:  2022-08-22

3.  New Avenues to Design Toxoplasma Vaccines Based on Oocysts and Cysts.

Authors:  David Arranz-Solís; Jeroen P J Saeij
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.